Clinical Features of 29 Patients with Hereditary Tyrosinemia I in Western Turkey
Makaleler > Tam Makale · 2018
Yazarlar: Havva YAZICI, Esra Er, Ebru CANDA, Sara HABİF, Sema KALKAN UÇAR, Mahmut ÇOKER
JOURNAL OF PEDIATRIC RESEARCH, SCI Expanded İndekslerine Giren Dergi, Uluslararası, 2018, cilt 5, ss 1-6
DOI: 10.4274/jpr.00710
Özet
Aim: The aim of this study was to investigate the long-term outcome of hereditary tyrosinemia Type I (HTI) patients treated with 2-(2-nitro-4-trifluoromethylbenzoyl)-1-1,3-cyclohexanedione (NTBC) to increase knowledge about the clinical outcome in these patients. We want to mention that the patients with HTI have heterogeneous clinic Early diagnosis and early treatment important to prevent the complications.